← Eichor
Condition: Malignant Oral Cavity Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Oral Cavity Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Phase N/A · 5 location(s) · AZ Sint-Jan AV · NCT04007783A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders
NA · 1 location(s) · Universidad Rey Juan Carlos · NCT05562375Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 · 7 location(s) · M.D. Anderson Cancer Center · NCT04870762Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899High-Resolution PET-CT Imaging for Surgical Margin Visualization
NA · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06915454Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04879121Physiologic MR Imaging of Salivary Gland Tumors
NA · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT04452162SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462RAPA-201 Therapy of Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Rapa Therapeutics LLC · NCT05144698Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest
Phase 2 · 1 location(s) · Mayo Clinic · NCT06997068Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-C
NA · 34 location(s) · NRG Oncology · NCT06279013Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT03975322A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/Phase 2 · 5 location(s) · 7 Hills Pharma, LLC · NCT06362369Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)
NA · 1 location(s) · Dalarna County Council, Sweden · NCT05296941Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03093909Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral
Phase 4 · 1 location(s) · M.D. Anderson Cancer Center · NCT04265430The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorde
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT06535867Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center
Phase N/A · 1 location(s) · Catholic University of the Sacred Heart · NCT06934863Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT04068155Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01473784Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01269190A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1 · 32 location(s) · Kura Oncology, Inc. · NCT06655246
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.